chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Nausea, Pain, Pyrexia
Clinical narrative: Hives on lower trunk; Vaccination site pain; Fatigue; Headache; Chills; Body aches; Fever 99.4; Nausea; General malaise; Brain fog; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled depression, anxiety, COVID-19 and mildly intolerant to gluten. Patient was allergic to ibuprofen (MOTRIN). Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) 15mg and ethinylestradiol, drospirenone (NIKKI); both from an unknown date and for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Apr2021 at 20:00, the patient experienced hives on lower trunk and extremities continuing 96 hours after administered, injection site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 03Apr2021, the patient body temperature was measured and the result was 99.4 (units unspecified). The clinical outcome of the event hives on lower trunk, vaccination site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, swollen lymph nodes were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site pain
Clinical narrative: Hives on lower trunk; Vaccination site pain; Fatigue; Headache; Chills; Body aches; Fever 99.4; Nausea; General malaise; Brain fog; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled depression, anxiety, COVID-19 and mildly intolerant to gluten. Patient was allergic to ibuprofen (MOTRIN). Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) 15mg and ethinylestradiol, drospirenone (NIKKI); both from an unknown date and for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Apr2021 at 20:00, the patient experienced hives on lower trunk and extremities continuing 96 hours after administered, injection site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 03Apr2021, the patient body temperature was measured and the result was 99.4 (units unspecified). The clinical outcome of the event hives on lower trunk, vaccination site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, swollen lymph nodes were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Gait disturbance, Vaccination site pain
Clinical narrative: Not under her arm was sore but down the vaccination site; Couldn't breath; Legs could not hardly walk; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (Reporter's mother). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing she had Covid. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced not under her arm was sore but down the vaccination site, could not breathe, legs could not hardly walk. It was reported that reporter's mother (consumer), took Pfizer the shot yesterday and she had Covid already, but she had it in October, she still has a little bit of side effects with it, she said that under her arm was sore and she was having little bit of could not breath and her legs could not hardly walk. When paraphrased the concern, reporter stated, Yes, she said under her arm like down on the side, sore, not her arm but down the site of her the (vaccination) site where shot was. The outcome of the events were reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Palpitations
Clinical narrative: Heart racing and pounding; light headed; felt really hot; This is a spontaneous report received from contactable female consumer (patient) via Pfizer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 05Apr2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not re-ported. On an unspecified date in Apr2021, the patient experienced heart racing and pounding, light-headed, felt really hot after her first dose but after a few minutes it was all gone. Patient was asking if she can still take the 2nd dose. The medical questions were addressed by this program forwarded/referred to Medical Information. The outcome of events was recovered on an unspecified date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: Fever 100.1 F; Chills; Muscle aches; Sore throat; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included lamotrigine (LAMICTAL), bupropion hydrochloride (WELLBUTRIN), methylphenidate (MANUFACTURER UNKNOWN) and ethinylestradiol; ferrous fumarate; norethisterone acetate (JUNEL FE). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021, the patient experienced a fever of 100.1 Fahrenheit (F), chills, muscle aches, sore throat and headache. The patient underwent a body temperature test on 07Apr2021, and the result was observed to be a temperature of 100.1 F. Therapeutic measures were not taken as a result of the events fever of 100.1 F, chills, muscle aches, sore throat and headache. The clinical outcome of the events fever of 100.1 F, chills, muscle aches, sore throat and headache was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 100.1 F; Chills; Muscle aches; Sore throat; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included lamotrigine (LAMICTAL), bupropion hydrochloride (WELLBUTRIN), methylphenidate (MANUFACTURER UNKNOWN) and ethinylestradiol; ferrous fumarate; norethisterone acetate (JUNEL FE). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021, the patient experienced a fever of 100.1 Fahrenheit (F), chills, muscle aches, sore throat and headache. The patient underwent a body temperature test on 07Apr2021, and the result was observed to be a temperature of 100.1 F. Therapeutic measures were not taken as a result of the events fever of 100.1 F, chills, muscle aches, sore throat and headache. The clinical outcome of the events fever of 100.1 F, chills, muscle aches, sore throat and headache was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 18.0
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: heart palpitations; This is a Spontaneous report from a contactable Consumer. The contactable consumer (patient, self-reported) reported in response to the Non-HCP letter that was sent included  A 18-years-old patient of unspecified gender received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9269 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 03Feb2021 at 09:30 AM (age at vaccination: 18 years), as a single dose for COVID-19 immunization at public health clinic. Vaccine was not administered at  facility. The patient's medical history included Postral orthastatic tacacardia syndrome (POTS) from Jul2017 and Wilkies syndrome (pertinent details: gastric bypass). Concomitant medication included omeprazole (PRILOSEC) for heartburn. The patient did not receive any vaccine within 4 weeks prior vaccinations. On 03Feb2021 at 21:30, the patient experienced heart palpitations. The patient did not receive any treatment for the event. Outcome of the event was recovered on an unspecified date.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Mobility decreased, Sciatica
Clinical narrative: Today is mild discomfort and fair to good mobility; Sciatica; The pain I experienced Sun through Tue limited my mobility significantly and I had trouble sitting and changing positions.; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 02Apr2021 at 10:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included no diagnosed illnesses and no chronic health conditions. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 07:00, the patient experienced sciatica. Sciatica was really bad on Sunday through Tuesday. The patient had never had sciatica and the pain he experienced Sunday through Tuesday limited the patient's mobility significantly and he had trouble sitting and changing positions. The patient did not know if it was coincidental but he had never had sciatica ever before. The pain was concentrated below his hip on the outside. He would occasionally have shooting pains with tingling down his leg. It was a bizarre experience. On 07Apr2021, the patient experienced mild discomfort and fair to good mobility and sciatica was much better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sciatica was really bad on Sunday through Tuesday, limited the patient's mobility significantly and he had trouble sitting and changing positions and mild discomfort was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in jaw
Clinical narrative: Sore neck; Sore jaw; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 07Apr2021 at 09:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included an allergy to latex powder. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, on the same day of vaccination, the patient experienced a sore neck and a sore jaw. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore neck and sore jaw were recovered on 07Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Myalgia, Sensitive skin, Skin burning sensation
Clinical narrative: Became very hot; Skin very sensitive to touch; headache; muscle aches; very sensitive to touch and almost like a sun burn feeling; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the arm left on 06Apr2021 at 10:00(at the age of 49-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications included eszopiclone (MANUFACTURER UNKNOWN, 3mg) and DESVENLAFAXINE SUCCNT ER both from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the arm left on 14Mar2021 at 17:15 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 patient experienced (Feeling hot)Became very hot, her skin (all over) was very sensitive to touch(sensitive skin) and almost like a sun burn feeling(burning skin). she also got bad headache (headache) and muscle aches (muscle ache). All of this began approx 10-12 hours after shot and lasted about 14 hours. The clinical outcome of the events became very hot, Skin very sensitive to touch, burning skin, headache and muscle aches were resolving.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Felt like a bad wasp/hornet sting that burned.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: LOTER2613) via an unspecified route of administration in the arm right on 01Apr2021 at 12:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included diffuse cutaneous mastocytosis, osteoarthritis and attention deficit disorder (ADD). The patient received unspecified medications within two weeks of vaccination. The patient previously took codeine on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 12:15, the patient experienced vaccination site burning from the moment the injection started, the patient felt like she was being stung by a wasp or hornet. The patient never had that sensation with any other vaccine (or needle injection of any kind). For several hours after the injection it continued to felt like a bad wasp/hornet sting that burned. The patient iced it several times. The patient had cutaneous mastocytosis. The patient saw the release from) of a study to look at mast cells in adverse reactions to the vaccines, the patient thought perhaps mastocytosis might be linked to the immediate burning session that the patient experienced and then lasted for several hours. Therapeutic measures were not taken as a  result of the events. The events did not result in doctor or other healthcare professional  office/clinic visit, emergency room/department or  urgent care. The clinical outcome of the event injection felt like a bad wasp/hornet sting that burned (vaccination site burning) was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia
Clinical narrative: CHILLS FOR 5 HOURS; Loss of sleep; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issue. The patient had no known allergies to medications, food or other products. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via unspecified route of administration in the left arm on 07Mar2021 at 12:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021 at 23:00, ten hours after the vaccination, the patient experienced chills for 5 hours and loss of sleep. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events chills and loss of sleep. The clinical outcome of the event chills was resolved on 07Apr2021 at 04:00 and the clinical outcome of the event loss of sleep was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Fatigue, Hyperglycaemia, Nausea, Oropharyngeal pain
Clinical narrative: Sore Arm; Sore Throat; Fatigue; Nausea; Sugars running high; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 03Apr2021 at 16:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. Concomitant medications included levofloxacin (LEVOXIN), insulin lispro (HUMALOG) and insulin glargine (LANTUS), all from an unknown start date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 13Mar2021 at 16:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 next day after the vaccine, the patient experienced sore arm, sore throat, fatigue, nausea and sugars were running high (patient type 1 diabetic). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events sore arm, sore throat, fatigue, nausea and sugars were running high was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; Sore Throat; Fatigue; Nausea; Sugars running high; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 03Apr2021 at 16:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. Concomitant medications included levofloxacin (LEVOXIN), insulin lispro (HUMALOG) and insulin glargine (LANTUS), all from an unknown start date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 13Mar2021 at 16:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 next day after the vaccine, the patient experienced sore arm, sore throat, fatigue, nausea and sugars were running high (patient type 1 diabetic). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events sore arm, sore throat, fatigue, nausea and sugars were running high was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, SARS-CoV-2 test, Urticaria
Clinical narrative: Face became itchy / Whole body became itchy; Hive in random places; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts, egg, shellfish, peanut, coconut and pet dander. Concomitant medications included fluticasone (MANUFACTURER UNKNOWN) and norethidrone acetate-ethinylestradiol (MANUFACTURER UNKNOWN), both taken for unspecified indications from unknown dates. The patient previously took amoxicillin and tramadol and experienced drug allergy with both. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 11:00, about 30 minutes after the vaccination, the patient experienced that her face became itchy, over the next 3 hours her whole body became itchy, there was no visible rash and she had hives in random places (two on face, one on neck, one on back, one in armpit). Even after 9 hours the patient felt itchy. On an unknown date, the patient underwent COVID-19 test (nasal swab) and the result was negative. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events face and whole body were itchy and hives were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Fatigue
Clinical narrative: Mild chills; fatigue; Mild tenderness in the armpit of my left arm.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome. The patient did not have any allergies to medications, food, or other products. Concomitant medications included vitamin d nos, fish oil and multi vitamins; al from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 for COVID-19 immunisation (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 09:00, the patient experienced mild chills, fatigue and mild tenderness in the armpit of left arm. The patient did not receive any treatment for the events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event's mild chills, fatigue and mild tenderness in the armpit of left arm were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Excessive nose bleeding from both sides. Non-stop dripping 1+drops per second for 30 minutes +/-, 3-4 episodes per day for three days. Started from day 2 after second dose.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 16:45 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 at 16:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included lower back pain and allergy to sulfonamide and pollens. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and multivitamins, all from unknown date for unknown indication taken within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, the patient experienced excessive nose bleeding from both sides. The patient reported that it was non-stop dripping more than 1 drop per second for 30 minutes or so for 3-4 times per day for three days. This event started from day 2 after second dose. there was no irritation or any touching to trigger. The patient experienced one such episode after 1st dose and before 2nd dose and he had more than 10 episodes after the 2nd dose. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. The clinical outcome of the event nose bleeding was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Headache, Swelling, Vaccination site pain
Clinical narrative: sore at injection site; sore under arm; headache; fatigue; swollen in area between collarbone and neck on side where shot was given; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in left arm on 06Apr2021 at 13:00 (at the age of 48 year-old) as single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient received other medication(unspecified) in two weeks of vaccination. The patient previously received first dose of BNT162b2(PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in left arm on 13Mar2021 at 12:00 (at the age of 48 year-old) as single dose for COVID-19 immunisation.  The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 06Apr2021 at 15:00, the patient experienced sore at injection site(vaccination site), sore under arm, headache, fatigue, and swollen in area between collarbone and neck on side where shot was given. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event sore at injection site, sore under arm, headache, fatigue, and swollen in area between collarbone and neck were not recovered at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained
Sex: U
Vaccine: COVID19
Symptoms: Epicondylitis
Clinical narrative: Third day, severe tennis elbow on right arm; One week later, tennis elbow on left arm; This is a spontaneous report from a contactable consumer, the patient. An unknown gender patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, third day after vaccination, the patient experienced severe tennis elbow on right arm. On an unknown date in Mar2021, one week later after vaccination, the patient experienced tennis elbow on left arm. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measure was taken as a result of the reported adverse events. The clinical outcome of the event severe tennis elbow on right arm and tennis elbow on left arm were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Red knuckles on hands; Itchy knuckles on hands and a bit on feet; Red and itchy feet; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 06Apr2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) and fexofenadine hydrochloride (ALLEGRA), all from an unknown date for an unknown indication. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 16Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced red and itchy knuckles on hands (mostly the left hand which is the side of the vaccine) and also a bit on feet. No therapeutic measures were taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events red hands, itchy and redness on legs was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Feeling abnormal, Malaise, Pyrexia
Clinical narrative: dizziness; feeling unwell; low grade fever; joint pain; cloudy in head; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Box # 18) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medications 2 weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced dizziness, feeling unwell, low grade fever, joint pain and cloudy in head. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcome of the events dizziness, feeling unwell, low grade fever, joint pain and foggy feeling in head were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass, Pain
Clinical narrative: developed a lump above collarbone and is about the size of a nickel and is hard and immovable; It does hurt similar to a sensitive bruise; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 11:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history included scoliosis. Concomitant medication included MONOLINYAH started on an unknown date for birth control. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 11:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Feb2021 at 10:00, the patient experienced a lump above the collarbone(neck mass) which was about the size of a nickel and was hard and immovable and hurt similar to a sensitive bruise. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events a lump above the collarbone and hurt similar to a sensitive bruise was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Migraine, Nausea, Palpitations, Pyrexia
Clinical narrative: High fever; Migraine headache; Achy shoulders; Achy hips; Nausea; Racing heart beat; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 16:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient has no allergies to food, medication or other products. Concomitant medications included biotin (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), zinc (MANUFACTURER UNKNOWN), glucosamine (MANUFACTURER UNKNOWN) and cholecalciferol (VIT D-3) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 10:00 the patient experienced high fever, migraine head ache, achy shoulders, achy hips, nausea and racing heartbeat. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events high fever, migraine head ache, achy shoulders, achy hips, nausea and racing heartbeat were not recovered at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass
Clinical narrative: Lump on neck; This is a spontaneous report from a contactable consumer. A 46-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. It was unknown whether the patient had any medical history. It was unknown whether patient had any allergies to medications, food, or other products. It was unknown whether patient received any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced lump on neck. It was unknown whether any therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event of lump on neck was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: Chills; fever; body aches; stomach ache; Dizziness; Weakness; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had drug allergy to augmentin and sulfa drugs. Concomitant medications included escitalopram (MANUFCTURER UNKNOWN) within 2 weeks of vaccination for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 13Mar2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 23:30, the patient experienced chills, fever, body aches, stomach ache, dizziness, weakness and diarrhea. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event chills, fever, body aches, stomach ache, dizziness, weakness and diarrhea were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Chills; fever; body aches; stomach ache; Dizziness; Weakness; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had drug allergy to augmentin and sulfa drugs. Concomitant medications included escitalopram (MANUFCTURER UNKNOWN) within 2 weeks of vaccination for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 13Mar2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 23:30, the patient experienced chills, fever, body aches, stomach ache, dizziness, weakness and diarrhea. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event chills, fever, body aches, stomach ache, dizziness, weakness and diarrhea were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Got an unscheduled period three weeks early; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Apr2021, a week after receiving the vaccine the patient experienced an unscheduled period three weeks early. The patient had never missed period neither was late or gotten it early. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event irregular period was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: The very worst of the headaches was a week after shot, with very bad total body muscle aches for one day.; Bad headaches started the next day.  I have continued to have the painful headaches most of the days since getting the 1st dose of pfizer vaccine, including today, about 3 weeks later. The very worst of the headaches was a week after shot; This is a spontaneous report from a contactable consumer, the patient. An adult non-pregnant female patient of unspecified age received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6205) via an unspecified route of administration in the left arm on 18Mar2021, as a single dose for COVID-19 immunisation. The patient had no medical history and did not receive any concomitant medications. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Mar2021, the patient experienced bad headaches that started the next day. The patient continued to have the painful headaches most of the days since getting the first dose of Pfizer vaccine, including the day of reporting, about 3 weeks later. The very worst of the headaches was a week after shot, with very bad total body muscle aches for one day on 25Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event bad headaches that started the next day was not recovered while that of very bad total body muscle aches for one day was recovered on 26Mar2021.   No follow-up attempts are needed. No further information is expected.